Tenax Therapeutics, Inc.
TENX
$5.80
$0.030.52%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -128.27% | -107.01% | -57.58% | -3.80% | 30.20% |
| Total Depreciation and Amortization | -- | -84.11% | -89.77% | -91.80% | -92.94% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 431.28% | -15.45% | -19.06% | -24.69% | -41.10% |
| Change in Net Operating Assets | 3.79% | 477.49% | 1,868.90% | 154.60% | 292.86% |
| Cash from Operations | -150.86% | -94.13% | -49.37% | 8.17% | 48.16% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -92.86% | -92.86% | 50.00% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -97.06% | -97.06% | -65.38% | 230.43% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 19.72% | -690.52% | -9,360.00% | -2,477.08% | -624,000.00% |
| Issuance of Common Stock | 592.89% | 592.89% | -42.31% | -62.31% | 82.58% |
| Repurchase of Common Stock | -592.47% | -72.89% | -82.62% | -82.62% | -82.62% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 606.76% | 79.00% | 84.85% | 84.85% | 79.00% |
| Cash from Financing | 636.02% | 624.79% | -46.17% | -65.57% | 71.09% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,009.27% | 1,088.43% | -165.05% | -116.16% | 321.61% |